Literature DB >> 3539800

Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.

S A Stimpson, R A Lerch, D R Cleland, D P Yarnall, R L Clark, W J Cromartie, J H Schwab.   

Abstract

Purified group A streptococcal peptidoglycan-polysaccharide (PG-PS) fragments were either de-O-acylated, or acetylated and then de-O-acylated to yield N-acetylated PG-PS. Native PG-PS was poorly degraded, N-acetylated PG-PS was extensively degraded, and de-O-acylated PG-PS was only slightly degraded by hen egg white lysozyme. N-acetylated PG-PS was also extensively degraded by human lysozyme and partially degraded by rat serum or rat liver extract. After a single intraperitoneal injection of rats with a sterile, aqueous suspension, all PG-PS preparations induced acute arthritis. The acute arthritis induced by N-acetylated PG-PS was significantly more severe than that induced by native PG-PS; that induced by de-O-acylated PG-PS was of intermediate severity. After the acute reaction, rats injected with native PG-PS developed chronic relapsing erosive synovitis which remained severe for the duration of the experiment (83 days). In contrast, joint inflammation induced by N-acetylated PG-PS resolved within 6 weeks with little evidence of recurrent disease. Chronic arthritis induced by de-O-acylated PG-PS was of intermediate severity. In another assay of arthropathic activity, the arthritis in all rat ankle joints, which had been injected directly with native PG-PS, could be reactivated 3 weeks later by the intravenous injection of a small dose of PG. In contrast, only 50% of the joints initially injected with de-O-acylated PG-PS and none of the joints injected with N-acetylated PG-PS could be reactivated. These studies support the concepts that the resistance of PG-PS to muralytic digestion is crucial for chronic arthropathic activity and that the nature and degree of PG acetylation are important molecular determinants of the phlogistic activities of PG-PS polymers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3539800      PMCID: PMC260274          DOI: 10.1128/iai.55.1.16-23.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  STRUCTURE OF STREPTOCOCCAL CELL WALLS. 3. CHARACTERIZATION OF AN ALANINE-CONTAINING GLUCOSAMINYLMURAMIC ACID DERIVATIVE LIBERATED BY LYSOZYME FROM STREPTOCOCCAL GLYCOPEPTIDE.

Authors:  H HEYMANN; J M MANNIELLO; S S BARKULIS
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  Development of lysozyme-resistance in Micrococcus lysodiekticus and its association with an increased O-acetyl content of the cell wall.

Authors:  W BRUMFITT; A C WARDLAW; J T PARK
Journal:  Nature       Date:  1958-06-28       Impact factor: 49.962

3.  Occurrence of N-nonsubstituted glucosamine residues in peptidoglycan of lysozyme-resistant cell walls from Bacillus cereus.

Authors:  Y Araki; T Nakatani; K Nakayama; E Ito
Journal:  J Biol Chem       Date:  1972-10-10       Impact factor: 5.157

4.  Biological properties of streptococcal cell-wall particles. 3. Dermonecrotic reaction to cell-wall mucopeptides.

Authors:  E M Abdulla; J H Schwab
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

5.  In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.

Authors:  M J Janusz; R E Esser; J H Schwab
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

6.  Arthropathic properties of cell wall polymers from normal flora bacteria.

Authors:  S A Stimpson; R R Brown; S K Anderle; D G Klapper; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

7.  Lysis of grouped and ungrouped streptococci by lysozyme.

Authors:  S E Coleman; I van de Rijn; A S Bleiweis
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

8.  Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat.

Authors:  R L Wilder; G B Calandra; A J Garvin; K D Wright; C T Hansen
Journal:  Arthritis Rheum       Date:  1982-09

9.  Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  16 in total

1.  PGLYRP-2 and Nod2 are both required for peptidoglycan-induced arthritis and local inflammation.

Authors:  Sukumar Saha; Jin Qi; Shiyong Wang; Minhui Wang; Xinna Li; Yun-Gi Kim; Gabriel Núñez; Dipika Gupta; Roman Dziarski
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

2.  Degradation of gonococcal peptidoglycan by granule extract from human neutrophils: demonstration of N-acetylglucosaminidase activity that utilizes peptidoglycan substrates.

Authors:  R Striker; M E Kline; R A Haak; R F Rest; R S Rosenthal
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

3.  Tough nuts to crack: site-directed mutagenesis of bifidobacteria remains a challenge.

Authors:  Vincenzo F Brancaccio; Daria S Zhurina; Christian U Riedel
Journal:  Bioengineered       Date:  2013-01-11       Impact factor: 3.269

4.  Otitis media induced by peptidoglycan-polysaccharide (PGPS) in TLR2-deficient (Tlr2(-/-)) mice for developing drug therapy.

Authors:  Xiaolin Zhang; Tihua Zheng; Lu Sang; Luke Apisa; Hongchun Zhao; Fenghua Fu; Qingzhu Wang; Yanfei Wang; Qingyin Zheng
Journal:  Infect Genet Evol       Date:  2015-08-18       Impact factor: 3.342

5.  Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis.

Authors:  E Simelyte; M Rimpiläinen; X Zhang; P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

Review 6.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

7.  Bacterial cell wall polymers (peptidoglycan-polysaccharide) cause reactivation of arthritis.

Authors:  S N Lichtman; S Bachmann; S R Munoz; J H Schwab; D E Bender; R B Sartor; J J Lemasters
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Histology of joint inflammation induced in rats by cell wall fragments of the anaerobic intestinal bacterium Eubacterium aerofaciens.

Authors:  A J Severijnen; R van Kleef; A A Grandia; T H van der Kwast; M P Hazenberg
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

9.  Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora.

Authors:  A J Severijnen; R van Kleef; M P Hazenberg; J P van de Merwe
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

10.  Nonoxidative antimicrobial effects of human polymorphonuclear leukocyte granule proteins on Chlamydia spp. in vitro.

Authors:  K B Register; C H Davis; P B Wyrick; W M Shafer; J K Spitznagel
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.